Mihai Azimioara

This inventor holds 11 USPTO granted patents and 9 published patent applications and 5 EPO patents. Top assignees: Irm LLC, Arena Pharmaceuticals, Inc., Novartis Ag. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mihai Azimioara. Retrieved from https://idiyas.com/inventor/mihai-azimioara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 9)

% Patents Active = 18.2

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

La Jolla, CA (US) (2010 - 2021)
San Diego, CA (US) (2013 - 2023)

Company Filing History:

Arena Pharmaceuticals, Inc.

Years Active: 2010-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11807620 - Quinazolinone compounds and related compounds (2023-11-07),

2. 11066369 - N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease (2021-07-20),

3. 10450273 - N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease (2019-10-22),

4. 8933083 - 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia (2015-01-13),

5. 8575168 - Compounds and compositions as modulators of GPR119 activity (2013-11-05),

6. 8394841 - Compounds and methods for modulating G protein-coupled receptors (2013-03-12),

7. 8293751 - 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia (2012-10-23),

8. 8258156 - Compounds and compositions as modulators of GPR119 activity (2012-09-04),

9. 8153635 - Compounds and compositions as modulators of GPR119 activity (2012-04-10),

10. 7820705 - Compounds and compositions as PPAR modulators (2010-10-26),

11. 7745445 - Compounds and compositions as PPAR modulators (2010-06-29),

Title: Mihai Azimioara: Innovator in Pharmaceutical Compounds

Introduction

Mihai Azimioara is a prominent inventor based in La Jolla, California, known for his significant contributions to the field of pharmaceutical compounds. With a total of 11 patents to his name, he has made remarkable strides in developing innovative solutions for various medical conditions.

Latest Patents

Among his latest patents are the quinazolinone compounds and related compounds. These compounds are designed to treat diseases, disorders, or conditions associated with unregulated protein function and levels. Another notable patent involves N-(pyridin-2-yl)pyridine-sulfonamide derivatives, which are capable of modulating the activity of CFTR. This invention also includes methods for manufacturing these compounds and their therapeutic applications, particularly in the treatment of cystic fibrosis and related disorders.

Career Highlights

Mihai has worked with several notable companies throughout his career, including Irm LLC and Arena Pharmaceuticals, Inc. His work in these organizations has allowed him to further his research and development efforts in the pharmaceutical industry.

Collaborations

Mihai has collaborated with esteemed colleagues such as Robert Epple and Victor Ivanovich Nikulin. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Mihai Azimioara's work in the field of pharmaceutical compounds showcases his dedication to innovation and improving healthcare solutions. His numerous patents reflect his expertise and commitment to addressing complex medical challenges.

Profile summary based on public USPTO records.